Abstract 4359292: Aldosterone dysregulation is associated with uncontrolled hypertension: Insights from the real-world BREAKTHROUGH Hypertension Study

Background: Association between serum aldosterone levels and uncontrolled hypertension in a real-world diverse population remains understudied. Aim: To evaluate the relationship between systolic blood pressure (SBP) and aldosterone dysregulation among patients with essential hypertension. Methods: Patients with essential hypertension who underwent serum aldosterone measurement between 1/1/2022 and 7/31/2024 were assessed. Patients were divided into cohorts based on SBP ≥130 mmHg (uncontrolled) vs. <130 mmHg and compared according to aldosterone levels, plasma renin activity (PRA), and plasma renin concentration (PRC). Aldosterone dysregulation was defined as aldosterone-to-PRA ratio ≥10 or aldosterone-to-PRC ratio ≥1, and compared with no aldosterone dysregulation group (aldosterone-to-PRA ratio <10 or aldosterone-to-PRC ratio <1), in multivariate logistic regression models adjusted for serum potassium, diabetes, inpatient vs outpatient status, and assay type (immunoassay vs chromatography). Results: Of the 9129 essential hypertension patients, 7169 (79%) had uncontrolled SBP. Compared to patients with controlled SBP, those with uncontrolled SBP were older, and more like to be males and have diabetes. Patients with controlled SBP showed higher baseline PRA (1.6 vs 1 ng/mL/h; p-value<.0001), PRC (13.3 vs 8.9 pg/mL; p-value<.0001), lower aldosterone-to-PRA ratio (4.3 vs 5.7; p-value<.0001) and aldosterone-to-PRC ratio (0.9 vs 1.2; p-value<.0001), compared with patients with SBP ≥130 mmHg. ( Table ) Both patients with controlled and uncontrolled SBP experienced aldosterone dysregulation (31.9% vs 41.5% respectively). Patients with aldosterone dysregulation had increased risk of uncontrolled SBP (OR 1.41 [1.26–1. 56]; p<0.0001) compared to those without aldosterone dysregulation. Stratified analyses by age, sex, race, and potassium status showed similar patterns. Conclusion: In patients with essential hypertension, aldosterone dysregulation was associated with increased risk of uncontrolled hypertension. This association was consistent regardless of demographics and potassium levels.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4359292
Primary Topic
Hormonal Regulation and Hypertension
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4359292: Aldosterone dysregulation is associated with uncontrolled hypertension: Insights from the real-world BREAKTHROUGH Hypertension Study

Jason A Ettlinger, Abiy Agiro, Monica Bennett, Muhammad Shamim Khan et al.
Circulation
Hormonal Regulation and Hypertension
article

Abstract 4359292: Aldosterone dysregulation is associated with uncontrolled hypertension: Insights from the real-world BREAKTHROUGH Hypertension Study

Jason A Ettlinger, Abiy Agiro, Monica Bennett, Muhammad Shamim Khan, Laurence L Somerville, Courtney Shaver, Francesco Fioretti, Kendall Hammonds, Elisa L. Priest, Shan Luan, Javed Butler
article en

Abstract

Background: Association between serum aldosterone levels and uncontrolled hypertension in a real-world diverse population remains understudied. Aim: To evaluate the relationship between systolic blood pressure (SBP) and aldosterone dysregulation among patients with essential hypertension. Methods: Patients with essential hypertension who underwent serum aldosterone measurement between 1/1/2022 and 7/31/2024 were assessed. Patients were divided into cohorts based on SBP ≥130 mmHg (uncontrolled) vs. <130 mmHg and compared according to aldosterone levels, plasma renin activity (PRA), and plasma renin concentration (PRC). Aldosterone dysregulation was defined as aldosterone-to-PRA ratio ≥10 or aldosterone-to-PRC ratio ≥1, and compared with no aldosterone dysregulation group (aldosterone-to-PRA ratio <10 or aldosterone-to-PRC ratio <1), in multivariate logistic regression models adjusted for serum potassium, diabetes, inpatient vs outpatient status, and assay type (immunoassay vs chromatography). Results: Of the 9129 essential hypertension patients, 7169 (79%) had uncontrolled SBP. Compared to patients with controlled SBP, those with uncontrolled SBP were older, and more like to be males and have diabetes. Patients with controlled SBP showed higher baseline PRA (1.6 vs 1 ng/mL/h; p-value<.0001), PRC (13.3 vs 8.9 pg/mL; p-value<.0001), lower aldosterone-to-PRA ratio (4.3 vs 5.7; p-value<.0001) and aldosterone-to-PRC ratio (0.9 vs 1.2; p-value<.0001), compared with patients with SBP ≥130 mmHg. ( Table ) Both patients with controlled and uncontrolled SBP experienced aldosterone dysregulation (31.9% vs 41.5% respectively). Patients with aldosterone dysregulation had increased risk of uncontrolled SBP (OR 1.41 [1.26–1. 56]; p<0.0001) compared to those without aldosterone dysregulation. Stratified analyses by age, sex, race, and potassium status showed similar patterns. Conclusion: In patients with essential hypertension, aldosterone dysregulation was associated with increased risk of uncontrolled hypertension. This association was consistent regardless of demographics and potassium levels.

CirculationVol. 152(Suppl_3)
AstraZeneca (United States) (US), Baylor Scott & White Health (US)
Openalex Percentile: Top 56%
Hormonal Regulation and Hypertension
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.